{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T20:05:26Z","timestamp":1785182726731,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,27]]},"DOI":"10.7759\/cureus.113464","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:26:46Z","timestamp":1785180406000},"source":"Crossref","is-referenced-by-count":0,"title":["Botulinum Toxin Type A for Cervicogenic Headache: A Review of the Current Evidence"],"prefix":"10.7759","author":[{"given":"Catarina","family":"Vasconcelos Fonseca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Cam\u00f5es-Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70209-1","article-title":"Cervicogenic headache: an assessment of the evidence on clinical diagnosis, invasive tests, and treatment","volume":"8","author":"Bogduk N","year":"2009","unstructured":"Bogduk N, Govind J. Cervicogenic headache: an assessment of the evidence on clinical diagnosis, invasive tests, and treatment. Lancet Neurol. 2009, 8:959-68. 10.1016\/S1474-4422(09)70209-1","journal-title":"Lancet Neurol"},{"key":"ref2","unstructured":"IHS classification ICHD-3. introduction to the secondary headaches. Accessed: July 20, 2026: https:\/\/ichd-3.org\/introduction-secondary-headaches\/."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5152\/balkanmedj.2012.003","article-title":"The efficacy of botulinum toxin in patients with cervicogenic headache: a placebo-controlled clinical trial","volume":"29","author":"Karada\u015f O","year":"2012","unstructured":"Karada\u015f O, Ozt\u00fcrk B, Ula\u015f UH, K\u00fct\u00fck\u00e7\u00fc Y, Odaba\u015f\u0131 Z. The efficacy of botulinum toxin in patients with cervicogenic headache: a placebo-controlled clinical trial. Balkan Med J. 2012, 29:184-7. 10.5152\/balkanmedj.2012.003","journal-title":"Balkan Med J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/ncn3.12787","article-title":"Association between trigeminal neuralgia and degenerative cervical myelopathy: a cross-sectional study using United States data","volume":"12","author":"Trager RJ","year":"2024","unstructured":"Trager RJ, Theodorou EC, Chu EC. Association between trigeminal neuralgia and degenerative cervical myelopathy: a cross-sectional study using United States data. Neurol Clin Neurosci. 2024, 12:88-94. 10.1111\/ncn3.12787","journal-title":"Neurol Clin Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnaa282","article-title":"Profiling the extent and location of pain in migraine and cervicogenic headache: a cross-sectional single-site observational study","volume":"21","author":"Uthaikhup S","year":"2020","unstructured":"Uthaikhup S, Barbero M, Falla D, Sremakaew M, Tanrprawate S, Nudsasarn A. Profiling the extent and location of pain in migraine and cervicogenic headache: a cross-sectional single-site observational study. Pain Med. 2020, 21:3512-21. 10.1093\/pm\/pnaa282","journal-title":"Pain Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2002.00390.x","article-title":"Treatment of headache with botulinum toxin A--a review according to evidence-based medicine criteria","volume":"22","author":"Evers S","year":"2002","unstructured":"Evers S, Rahmann A, Vollmer-Haase J, Husstedt IW. Treatment of headache with botulinum toxin A--a review according to evidence-based medicine criteria. Cephalalgia. 2002, 22:699-710. 10.1046\/j.1468-2982.2002.00390.x","journal-title":"Cephalalgia"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s101940200024","article-title":"Physical therapy and adjunctive botulinum toxin type A in the treatment of cervical headache: a double-blind, randomised, placebo-controlled study","volume":"3","author":"Schnider P","year":"2002","unstructured":"Schnider P, Moraru E, Vigl M, et al.. Physical therapy and adjunctive botulinum toxin type A in the treatment of cervical headache: a double-blind, randomised, placebo-controlled study. J Headache Pain. 2002, 3:93-9. 10.1007\/s101940200024","journal-title":"J Headache Pain"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.17712\/nsj.2024.4.20240012","article-title":"The Effects of cervical mobilization and clinical pilates exercises in cervicogenic headache: randomized controlled trial","volume":"29","author":"Uzun M","year":"2024","unstructured":"Uzun M, Ekmekyapar F\u0131rat Y, Ergun N, Akbayrak T. The Effects of cervical mobilization and clinical pilates exercises in cervicogenic headache: randomized controlled trial. Neurosciences (Riyadh). 2024, 29:231-8. 10.17712\/nsj.2024.4.20240012","journal-title":"Neurosciences (Riyadh)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/geriatrics10060155","article-title":"Efficacy and safety of incobotulinumtoxinA in older patients with upper limb spasticity: a pooled analysis","volume":"10","author":"Munin MC","year":"2025","unstructured":"Munin MC, Cam\u00f5es-Barbosa A, Cordero-Garc\u00eda C, et al.. Efficacy and safety of incobotulinumtoxinA in older patients with upper limb spasticity: a pooled analysis. Geriatrics (Basel). 2025, 10:10.3390\/geriatrics10060155","journal-title":"Geriatrics (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.48493","article-title":"Shoulder spasticity treatment with botulinum toxin: a nationwide cross-sectional survey of clinical practices","volume":"15","author":"Pinho S","year":"2023","unstructured":"Pinho S, Cam\u00f5es-Barbosa A, Hatia M, Moeda F, Melo X, Tocha J. Shoulder spasticity treatment with botulinum toxin: a nationwide cross-sectional survey of clinical practices. Cureus. 2023, 15:e48493. 10.7759\/cureus.48493","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.20344\/amp.11503","article-title":"Contralateral upper limb weakness following botulinum toxin A injection for poststroke spasticity","volume":"33","author":"Cam\u00f5es-Barbosa A","year":"2020","unstructured":"Cam\u00f5es-Barbosa A, Ribeiro IM, Medeiros L. Contralateral upper limb weakness following botulinum toxin A injection for poststroke spasticity. Acta Med Port. 2020, 33:761-4. 10.20344\/amp.11503","journal-title":"Acta Med Port"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.100675","article-title":"Management of complications following botulinum toxin facial injections: a narrative review","volume":"18","author":"Freixo S","year":"2026","unstructured":"Freixo S, Cam\u00f5es-Barbosa A. Management of complications following botulinum toxin facial injections: a narrative review. Cureus. 2026, 18:e100675. 10.7759\/cureus.100675","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.99201","article-title":"Idiopathic isolated focal jaw tremor responsive to botulinum toxin: a case report","volume":"17","author":"Peres R","year":"2025","unstructured":"Peres R, Godinho FD, Cam\u00f5es-Barbosa A. Idiopathic isolated focal jaw tremor responsive to botulinum toxin: a case report. Cureus. 2025, 17:e99201. 10.7759\/cureus.99201","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MRR.0000000000000495","article-title":"Botulinum toxin type A therapy for bilateral focal neuropathic pruritus in multiple sclerosis: a case report","volume":"44","author":"Portugal DM","year":"2021","unstructured":"Portugal DM, Ferreira EF, Cam\u00f5es-Barbosa A. Botulinum toxin type A therapy for bilateral focal neuropathic pruritus in multiple sclerosis: a case report. Int J Rehabil Res. 2021, 44:382-3. 10.1097\/MRR.0000000000000495","journal-title":"Int J Rehabil Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1590\/s0034-70942009000300013","article-title":"Botulinum toxin in pain treatment","volume":"59","author":"Colhado OC","year":"2009","unstructured":"Colhado OC, Boeing M, Ortega LB. Botulinum toxin in pain treatment. Rev Bras Anestesiol. 2009, 59:366-81. 10.1590\/s0034-70942009000300013","journal-title":"Rev Bras Anestesiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.18103\/mra.v11i5.3590","article-title":"Efficacy of incobotulinumtoxinA for spasticity-associated pain in a series of patients with spasticity of diverse etiologies","volume":"11","author":"Camoes-Barbosa A","year":"2023","unstructured":"Camoes-Barbosa A. Efficacy of incobotulinumtoxinA for spasticity-associated pain in a series of patients with spasticity of diverse etiologies. Med Res Arch. 2023, 11:10.18103\/mra.v11i5.3590","journal-title":"Med Res Arch"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13120887","article-title":"Pain reduction in adults with limb spasticity following treatment with incobotulinumtoxinA: a pooled analysis","volume":"13","author":"Wissel J","year":"2021","unstructured":"Wissel J, Cam\u00f5es-Barbosa A, Comes G, Althaus M, Scheschonka A, Simpson DM. Pain reduction in adults with limb spasticity following treatment with incobotulinumtoxinA: a pooled analysis. Toxins (Basel). 2021, 13:10.3390\/toxins13120887","journal-title":"Toxins (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.73389","article-title":"Botulinum toxin type A in trigeminal neuralgia treatment: a case series and literature review","volume":"16","author":"Santos RF","year":"2024","unstructured":"Santos RF, Machado M, Ferro M, Cam\u00f5es-Barbosa A. Botulinum toxin type A in trigeminal neuralgia treatment: a case series and literature review. Cureus. 2024, 16:e73389. 10.7759\/cureus.73389","journal-title":"Cureus"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jormas.2024.101804","article-title":"IncobotulinumtoxinA in refractory temporomandibular disorder due to disk dislocation: a prospective study","volume":"125","author":"Ferreira EF","year":"2024","unstructured":"Ferreira EF, Cam\u00f5es-Barbosa A. IncobotulinumtoxinA in refractory temporomandibular disorder due to disk dislocation: a prospective study. J Stomatol Oral Maxillofac Surg. 2024, 125:101804. 10.1016\/j.jormas.2024.101804","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmrj.2015.12.002","article-title":"The analgesic effect of abobotulinum and incobotulinum toxins type A in central poststroke pain: two case reports","volume":"8","author":"Camoes-Barbosa A","year":"2016","unstructured":"Camoes-Barbosa A, Neves AF. The analgesic effect of abobotulinum and incobotulinum toxins type A in central poststroke pain: two case reports. PM R. 2016, 8:384-7. 10.1016\/j.pmrj.2015.12.002","journal-title":"PM R"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2022\/52959.15957","article-title":"Botulinum neurotoxin injection as a therapeutic option in thoracic outlet syndrome caused by a supernumerary scalenus muscle: a case report","volume":"16","author":"Freitas M","year":"2022","unstructured":"Freitas M, Cam\u00f5es-Barbosa A. Botulinum neurotoxin injection as a therapeutic option in thoracic outlet syndrome caused by a supernumerary scalenus muscle: a case report. J Clin Diagn Res. 2022, 16:01-03. 10.7860\/JCDR\/2022\/52959.15957","journal-title":"J Clin Diagn Res"},{"key":"ref22","unstructured":"RoB 2 for crossover trials. (2021). Accessed. July 20, 2026: https:\/\/www.riskofbias.info\/welcome\/rob-2-0-tool\/rob-2-for-crossover-trials."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (MINORS): development and validation of a new instrument","volume":"73","author":"Slim K","year":"2003","unstructured":"Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (MINORS): development and validation of a new instrument. ANZ J Surg. 2003, 73:712-6. 10.1046\/j.1445-2197.2003.02748.x","journal-title":"ANZ J Surg"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2000.00033.x","article-title":"Treatment of chronic cervical-associated headache with botulinum toxin A: a pilot study","volume":"40","author":"Freund BJ","year":"2000","unstructured":"Freund BJ, Schwartz M. Treatment of chronic cervical-associated headache with botulinum toxin A: a pilot study. Headache. 2000, 40:231-6. 10.1046\/j.1526-4610.2000.00033.x","journal-title":"Headache"},{"key":"ref25","article-title":"Treatment of cervicogenic headache with botulinum toxin A: a double-blind trial","volume":"7","author":"Zhang Z","year":"2003","unstructured":"Zhang Z, Yao M, Zhang Y. Treatment of cervicogenic headache with botulinum toxin A: a double-blind trial. Chinese Journal of Clinical Rehabilitation. 2003, 7:260-1.","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1177\/0333102411398402","article-title":"Onabotulinum toxin A treatment of cervicogenic headache: a randomised, double-blind, placebo-controlled crossover study","volume":"31","author":"Linde M","year":"2011","unstructured":"Linde M, Hagen K, Salvesen \u00d8, Gravdahl GB, Helde G, Stovner LJ. Onabotulinum toxin A treatment of cervicogenic headache: a randomised, double-blind, placebo-controlled crossover study. Cephalalgia. 2011, 31:797-807. 10.1177\/0333102411398402","journal-title":"Cephalalgia"},{"key":"ref27","article-title":"Anxiety and depression levels in cervicogenic headache patients before and after botulinum toxin A treatment","volume":"21","author":"Karada\u015f \u00d6","year":"2011","unstructured":"Karada\u015f \u00d6, \u00d6zt\u00fcrk B, Zincir S, Tok F, \u00c7elik C, Odaba\u015f\u0131 Z. Anxiety and depression levels in cervicogenic headache patients before and after botulinum toxin A treatment. Bull Clin Psychopharmacol. 2011, 21:232-6.","journal-title":"Bull Clin Psychopharmacol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202","article-title":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition","volume":"38","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018, 38.1-211. 10.1177\/0333102417738202","journal-title":"Cephalalgia"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008626.pub4","article-title":"Botulinum toxin type A for subacute\/chronic neck pain","volume":"5","author":"Gross AR","year":"2026","unstructured":"Gross AR, Lee H, Chacko N, et al.. Botulinum toxin type A for subacute\/chronic neck pain. Cochrane Database Syst Rev. 2026, 5:CD008626. 10.1002\/14651858.CD008626.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.70219","article-title":"The comparative efficacy of treatments for cervicogenic headache: a systematic review and network meta-analysis of randomised controlled trials","volume":"30","author":"Koonalinthip N","year":"2026","unstructured":"Koonalinthip N, Koonalintip P, Stonsaovapak C. The comparative efficacy of treatments for cervicogenic headache: a systematic review and network meta-analysis of randomised controlled trials. Eur J Pain. 2026, 30:e70219. 10.1002\/ejp.70219","journal-title":"Eur J Pain"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/507304-botulinum-toxin-type-a-for-cervicogenic-headache-a-review-of-the-current-evidence","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:26:47Z","timestamp":1785180407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/507304-botulinum-toxin-type-a-for-cervicogenic-headache-a-review-of-the-current-evidence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.113464","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,27]]}}}